Baxter International, Inc.

920 articles with Baxter International, Inc.

• Baxter Receives NYSE Notice Regarding Delayed Form 10-Q Filing

  11/22/2019

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that the New York Stock Exchange (NYSE) notified the Company that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 with the Securities and Exchange Commission (SEC).

• Baxter Declares Quarterly Dividend Payable on January 2, 2020

  11/19/2019

  The dividend is payable on Jan. 2, 2020, to shareholders of record as of Dec. 6, 2019.

• Baxter to Present at the Evercore ISI 2nd Annual HealthCONx Conference

  11/6/2019

  Baxter International Inc., a leading global medical products company, will present at the Evercore ISI 2nd Annual HealthCONx Conference in Boston on December 4, 2019.

• Baxter to Present at the 28th Annual Credit Suisse Healthcare Conference

  10/29/2019

  Baxter International Inc., a leading global medical products company, will present at the 28th Annual Credit Suisse Healthcare Conference in Scottsdale, Ariz., on November 12, 2019.

• Baxter Reports Preliminary Third Quarter 2019 Operating Results

  10/24/2019

  The Company announces internal investigation of misstatements in previously reported non-operating income related to foreign exchange gains and losses

• Baxter Recognized as One of 2019 'Best Companies for Dads’ by Working Mother

  10/10/2019

  Baxter also recently named one of Working Mother’s 2019 ‘100 Best Companies’

• Baxter Home Dialysis Study Associates Sharesource With 39% Reduction in Hospitalization Rates for Colombian Patients

  10/1/2019

  Baxter International Inc., a global innovator in renal care, announced today new data associating the use of its automated peritoneal dialysis (APD) cyclers and the Sharesource remote patient management platform with a 39% reduction in hospitalizations for home PD patients receiving care at Baxter Renal Care Services clinics in Colombia.

• Baxter Features Patient-Centered Innovation at the 2019 European Society of Intensive Care Medicine Congress

  9/26/2019

  Baxter International Inc., a leading global medical products company, will showcase its latest product innovations at the 2019 European Society of Intensive Care Medicine (ESICM) LIVES congress in Berlin from Sept. 28 – Oct. 2.

• Latham & Watkins Advises Baxter International in Acquisition of Cheetah Medical

  9/13/2019

  Baxter International Inc., a leading global medical products company, has entered into a definitive agreement to acquire Cheetah Medical, an Israel-based leading provider of non-invasive hemodynamic monitoring technologies with offices in Boston, Massachusetts as well as Tel Aviv, as detailed in the company press release.

• Baxter Announces Acquisition of Cheetah Medical to Expand Specialized Patient Monitoring Portfolio

  9/10/2019

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, today entered into a definitive agreement to acquire Cheetah Medical, a leading provider of non-invasive hemodynamic monitoring technologies.

• Baxter to Host Third Quarter 2019 Financial Results Conference Call for Investors

  9/4/2019

  Thursday, October 24, 2019, at 7:30 a.m. Central Time.

• The Baxter International Foundation and Direct Relief Launch Program to Improve Diabetes Care in Underserved Communities

  8/21/2019

  Multi-year program begins in Greater Chicago area and will help safety-net health facilities across the United States

• Baxter and COSMED Announce Partnership to Bring Next-generation Indirect Calorimetry Device, Q-NRG+, to Support Clinical Nutrition Globally

  8/15/2019

  Non-invasive metabolic monitor accurately measures patient energy expenditure

• Baxter to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

  8/14/2019

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York on September 9, 2019.

• Georgia-based Hamilton Health Care System First in U.S. to Use New Baxter Technology in the ICU

  8/13/2019

  Baxter’s innovative PrisMax system for managing acute kidney injury (AKI) is now FDA cleared and available in the U.S.

• Baxter to Present at the 2019 Wells Fargo Healthcare Conference

  8/13/2019

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2019 Wells Fargo Healthcare Conference in Boston on September 5, 2019.

• Baxter Launches Prismax In Canada to Maximize Treatment in the Intensive Care Unit

  8/12/2019

  Next-generation platform for continuous renal replacement therapy is designed to simplify treatment delivery and accuracy

• Baxter Recognized With Highest Achievement on 2019 Diversity Best Practices Inclusion Index

  7/30/2019

  One of 14 organizations to qualify as a Top 10 Percent Inclusion Index Company

• Baxter Supports Add-on Payment in Proposed ESRD Payment Rule to Spur Innovation for Dialysis Patients

  7/30/2019

  Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today issued this statement

• Baxter Launches PrisMax in U.S. to Maximize Care for Critically Ill Patients

  7/29/2019

  Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced today 510(k) clearance of the PrisMax system and integrated TherMax blood warmer, the company’s next-generation platform for continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE).